With the growth of the marijuana industry and the recent introduction of a bill to allow more marijuana reasearch licenses to be granted by congres, are biotechs exposed to marijuana and the growth of CBD oil? My concern is that the overall demand for pain suppression prescriptions will drop and hit big pharma. Even if big pharpma gets in the game, I imagine the profit margin on CBD oil wont be nearly as lucrative as current options. Thoughts?
Submitted September 19, 2018 at 12:01PM by Saucepass87 https://ift.tt/2DaccLC
No comments:
Post a Comment